Hua Medicine (the "Company", Hong Kong Stock Exchange Stock Code: 2552) announced yesterday a positive profit alert for the first half of the year for the Company together with its subsidiaries. (the "Group").
Hua Medicine ("the Company", stock code: 2552.HK) announced today that the Company presented the latest research results of dorzagliatin, its global first-in-class glucokinase activator (GKA), at the 85th Scientific Sessions of the American Diabetes Association (ADA).
Hua Medicine ("the Company", stock code: 2552.HK) announced today that it will present the research results of dorzagliatin, the Company's global first-in-class glucokinase activator (GKA), at the 85th American Diabetes Association (ADA) Scientific Sessions.
ir@huamedicine.com
No.275 Ai Di Sheng Road, Zhangjiang Hi-Tech Park, Pudong, Shanghai 201203
沪公网安备 31011502013809号 Privacy Statement Terms of Use
